ResearcherUniversity of MichiganActive in the last 2 years
Yi Sun
Matched on ORCID iD 0000-0002-5841-4287; OpenAlex author ID A5051826848; NIH RePORTER profile ID 7840149. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 6)
- Trials
- 0
- Grants
- 1
- Labs led
- 2
- Collaborators
- 9
2012: 1 paper · 2013: none · 2014: 1 paper, 1 grant · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 6
- USP10 deubiquitylates and stabilizes DIRAS2 to suppress the growth of pancreatic cancer cells. Last author DOI 10.1002/mco2.751↗
- The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. Last author DOI 10.1016/j.devcel.2024.03.018↗
- Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model. Last author DOI 10.1016/j.neo.2020.03.002↗
- Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine. Last author DOI 10.1016/j.neo.2017.04.003↗
- DEPTOR has growth suppression activity against pancreatic cancer cells. Last author DOI 10.18632/oncotarget.2659↗
- Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Last author DOI 10.1158/0008-5472.can-11-2866↗
Grants 1
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qian Chen · 2 shared papers, 2024 · strength 0.60
- Hua Li · 4 shared papers, 2012–2024 · strength 0.39
- Paper The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. DOI 10.1016/j.devcel.2024.03.018↗
- Paper Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine. DOI 10.1016/j.neo.2017.04.003↗
- Paper DEPTOR has growth suppression activity against pancreatic cancer cells. DOI 10.18632/oncotarget.2659↗
- Yu Chang · 1 shared paper, 2024 · strength 0.24
- Meredith Ann Morgan · 2 shared papers, 2012–2020 · strength 0.17
- Paper Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the … DOI 10.1016/j.neo.2020.03.002↗
- Paper Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. DOI 10.1158/0008-5472.can-11-2866↗
- Dongping Wei · 2 shared papers, 2012–2020 · strength 0.17
- Paper Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the … DOI 10.1016/j.neo.2020.03.002↗
- Paper Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. DOI 10.1158/0008-5472.can-11-2866↗
- Qiang Zhang · 1 shared paper, 2020 · strength 0.13
- Edgar Ben‐Josef · 1 shared paper, 2014 · strength 0.04
- Mark M. Zalupski · 1 shared paper, 2014 · strength 0.04
- Theodore Steven Lawrence · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.